Digital Diagnostics – creator of LumineticsCore, the FDA De Novo cleared, fully autonomous AI system for the diagnosis of diabetic retinopathy, announces healthcare industry veteran, Kurt Blasena as its Chief Commercial Officer. Blasena joins the executive leadership team in the newly created Chief Commercial Officer role with a commitment to improving health equity and care quality through technology in the medical diagnosis and treatment process that is free of racial and ethnic bias.
This content is made possible by our sponsors. Submit your Movers & Shakers story here.
Kurt Blasena
